rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Montefiori, DC; Huang, Y; Karuna, S; Allen, M; Kochar, N; Chappuis, S; Gaillard, J; Tomaras, G; Graham, B; Bart, P; Pantaleo, G

Published Date

  • September 2012

Published In

Volume / Issue

  • 9 / S2

Published By

Electronic International Standard Serial Number (EISSN)

  • 1742-4690

Digital Object Identifier (DOI)

  • 10.1186/1742-4690-9-s2-p132